However, the results from these studies provided conflicting information concerning the expression of pRb and p16INK4a, and the prognostic significance of differential expression levels of these cellcycle regulatory proteins in ovarian carcinomas. The gene discussed is CDKN2A; the disease is ovarian carcinoma.